Why the study?
Does vitamin E ingestion cause coagulopathy in a patient taking warfarin and clofibrate?
Does vitamin E ingestion cause coagulopathy in a patient taking warfarin and clofibrate?
Vitamin E ingestion may increase the risk of hemorrhage in patients with vitamin K deficiency or those taking vitamin K antagonists like warfarin.
This is the authors' abstract. We don't add key points for this paper.
Although hypervitaminosis E causes a prolonged prothrombin time and a hemorrhagic state in animals, excessive vitamin E has not previously been found to cause bleeding in normal humans. We have seen a prolonged prothrombin time and ecchymoses develop in a patient who was taking warfarin sodium and clofibrate concomitant with self-administration of vitamin E. The prothrombin time returned to base line after vitamin E ingestion was stopped while warfarin and clofibrate treatment was continued. Coagulation studies demonstrated enhanced reduction of the levels of vitamin K-dependent coagulation factors during the period of vitamin E ingestion, which returned to base-line levels after the patient stopped taking the vitamin. Plasma warfarin levels did not change and platelet function remained normal. The data suggest that patients with vitamin K deficiency may risk hemorrhage if they take vitamin E. (JAMA230:1300-1301, 1974)
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for vitamin E potentiating warfarin coagulopathy; prospective studies needed before clinical adoption.
No takes yet. Share an insight, caveat, or question.
James J. Corrigan (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: